Effect of continuous intravenous administration of human metastin 45-54 on the neuroendocrine activity of the hypothalamic-pituitary-testicular axis in the adult male rhesus monkey (Macaca mulatta).
Ramaswamy. Suresh S; Seminara. Stephanie B SB; Pohl. Clifford R CR; DiPietro. Meloni J MJ; Crowley. William F WF; Plant. Tony M TM
Key Findings
- Continuous IV infusion of kisspeptin-10 initially raises LH, but the effect wanes within 24 hours due to GPR54 receptor desensitization.
- High‑dose continuous infusion suppresses LH pulse amplitude and frequency, and blunts the pituitary response to GnRH.
- Testosterone levels remain disproportionately high relative to LH during high‑dose infusion, suggesting a possible direct testicular action of kisspeptin.
Practical Outcomes
- For self‑experimenters, the data warn against using kisspeptin continuously or at very high doses, as the hormone’s signaling pathway can become desensitized, reducing LH spikes. Intermittent or low‑dose regimens are likely more effective for boosting LH and downstream testosterone. The unexpected rise in testosterone per LH hints at a potential direct testicular benefit, but this needs confirmation in humans before being used in protocols.
Summary
In adult male rhesus monkeys, giving kisspeptin-10 (metastin 45‑54) continuously through an IV caused a quick spike in the hormone LH, but after a few hours the LH levels fell back to normal because the receptor got desensitized. Surprisingly, even when LH was low, testosterone stayed higher than usual, hinting that kisspeptin might act directly on the testes.
Abstract
In agonadal juvenile male monkeys, continuous administration of human metastin 45-54 (hu metastin 45-54) leads to desensitization of its receptor, G protein-coupled receptor 54 (GPR54), and decreased LH. The present study extended this observation to the adult male monkey, a more preclinically relevant model in which robust activity in the hypothalamic-pituitary-testicular axis is present. Continuous iv infusion of hu metastin 45-54 at either 200 or 400 microg/h elicited a marked rise in circulating LH that peaked 2-3 h after initiation of treatment. Thereafter, levels declined, and by 24 h, LH in metastin 45-54-infused animals was similar to control. LH release in response to an iv bolus of hu metastin 45-54 (10-30 microg) during the final 3 h of continuous infusion was truncated or abolished (low and high peptide dose, respectively). GPR54 desensitization by the high-dose metastin 45-54 infusion was associated with compromised pituitary response to a bolus GnRH injection (0.3 microg). LH pulse amplitude and pulse frequency were markedly suppressed during high-dose metastin 45-54 treatment. Surprisingly, the fidelity of the relationship between circulating testosterone (T) and LH was distorted during the high-dose peptide infusion. Thus, for a given concentration of LH, T levels were invariably higher during the high-dose metastin 45-54 infusion than during vehicle, suggesting that the peptide may exert direct actions on the testis to amplify T production. These findings support the notion that GPR54 is desensitized by continuous exposure to ligand, and they raise the possibility of an intratesticular role of GPR54.
Study Information
pubmed
2007
2007-04-05T00:00:00.000Z
10.1210/en.2007-0207